Clinical studies with in-111 bledta, a tumor-imaging conjugate of bleomycin with a bifunctional chelating agent

D. A. Goodwin, C. F. Meares, L. H. Deriemer, C. I. Dlamanti, R. L. Goode, J. E. Baumert, D. J. Sartoris, R. L. Lantleri, H. D. Fawcett

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)123
Number of pages1
JournalNuclear Medicine Communications
Volume2
Issue number2
StatePublished - 1981

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Goodwin, D. A., Meares, C. F., Deriemer, L. H., Dlamanti, C. I., Goode, R. L., Baumert, J. E., Sartoris, D. J., Lantleri, R. L., & Fawcett, H. D. (1981). Clinical studies with in-111 bledta, a tumor-imaging conjugate of bleomycin with a bifunctional chelating agent. Nuclear Medicine Communications, 2(2), 123.